Business ❯ Pharmaceuticals

Corporate Governance

Legal Issues Mergers and Acquisitions Investigations Ethics Leadership Changes Executive Misconduct Executive Changes Investor Relations Family Business Executive Actions Investment Shareholders Glenmark Pharmaceuticals Shareholder Relations Supply Chain Management Contract Management Board Leadership Activism Executive Leadership Litigation Executive Management Management Fraud Investigation Executive Resignation Regulatory Compliance Board of Directors Legal Liability Executive Roles

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

The Indiana case cites regulatory disclosures following company claims about drug progress.

Novo Nordisk Foundation Installs Lars Rebien Sørensen as Chair After Shareholder Vote

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

GSK Taps Luke Miels as Next CEO Starting Jan. 1, 2026